기준가
$29.17
운용 규모
$82.3M
보수율
-
배당수익률
0.00%
베타
0.00
통화
USD
| YTD | 1개월 | 3개월 | 1년 | 3년 | 5년 |
|---|---|---|---|---|---|
| +10.81% | +3.14% | +6.99% | +17.30% | - | - |
| 순위 | 종목코드 | 종목명 | 비중 |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 3.27% |
| 2 | HSBA.L | HSBC Holdings PLC | 2.38% |
| 3 | 5802.T | Sumitomo Electric Industries Ltd | 2.13% |
| 4 | ROP.SW | Roche Holding AG Ordinary Shares new | 1.79% |
| 5 | SIE.DE | Siemens AG | 1.66% |
| 6 | BATS.L | British American Tobacco PLC | 1.45% |
| 7 | SHEL.L | Shell PLC | 1.32% |
| 8 | NOVN.SW | Novartis AG Registered Shares | 1.28% |
| 9 | CBA.AX | Commonwealth Bank of Australia | 1.23% |
| 10 | 8411.T | Mizuho Financial Group Inc | 1.22% |
The fund seeks to generate positive risk-adjusted returns by, under normal circumstances, investing at least 80% of its net assets (including any borrowings for investment purposes) in equity securities (including common stock and depositary receipts) issued by publicly listed companies in non-U.S. markets. The fund primarily invests in the securities of companies in countries with developed markets.
설정일: 2025-08-18